Aastrom Biosciences Inc. (ASTM) said the Food and Drug Administration cleared it to begin a 120-patient Phase III clinical trial to treat osteonecrosis, also known as avascular necrosis, of the femoral head. Osteonecrosis is a progressive disease that often leads to a total hip replacement.
Extended Hours:
Last 1.56
Change +0.12 (+8.33%)
we added this oddball a few weeks back....
http://www.buyonthedip.com/2007/04/oddball-friday-here-goes.html
TAKE SOME PROFITS as usual ....we love those 5 and 10% gains!
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment